NASDAQ
CytomX Therapeutics, Inc. (CTMX) has a fcf yield of -12.90% as of Friday, May 29, 2026. This represents a 82.78% increase compared to its 12-month average of -74.91%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.